Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 The results of heterogeneity test

From: Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test

Comparisons Coef. Std. Err. t P 95% CI
miRNA-130a
 Language − 0.408 0.382 − 1.07 0.327 − 1.342 to 0.528
 Publication year − 1.272 0.734 − 1.73 0.134 − 3.069 to 0.525
 Cancer type 0.549 0.710 0.77 0.469 − 1.188 to 2.287
 Ethnica
 Assaya
 Sample size − 0.279 0.372 − 0.75 0.481 − 0.630 to 1.189
 Follow-up − 0.308 0.378 − 0.81 0.446 − 1.235 to 0.617
 Cut-off − 0.506 0.385 − 1.31 0.237 − 1.447 to 0.436
miRNA-130b
 Languagea
 Publication year 0.306 0.458 0.67 0.523 − 0.751 to 1.362
 Cancer type − 0.001 0. 542 − 0.00 0.999 − 1.250 to 1.248
 Ethnic − 0.678 0.606 − 112 0.296 − 2.076 to 0.720
 Assaya
 Sample size 0.107 0.568 0.19 0.856 − 1.202 to 1.416
 Follow-up − 0.169 0.600 − 0.28 0.786 − 1.552 to 1.215
 Cut-off 0.178 0.318 0.56 0.591 − 0.556 to 0.912
  1. a Ethnic, language and assay were dropped because of collinearity